Nektar Therapeutics buy kyron7htx
Start price
28.09.13
/
50%
€7.70
Target price
11.11.13
€10.00
Performance (%)
4.69%
End price
11.11.13
€8.06
Summary
This prediction ended on 11.11.13 with a price of €8.06. With a performance of 4.69%, the BUY prediction by kyron7htx for Nektar Therapeutics closed with a slight gain. kyron7htx has 50% into this predictionNektar is a clinical-stage biopharmaceutical company focused on developing treatments for cancer, autoimmune diseases, and chronic pain. The company's pipeline includes product candidates based on its proprietary drug delivery technology, which improves the delivery and effectiveness of drugs in the body. Some of its most advanced candidates include NKTR-214, a cancer immunotherapy, and NKTR-181, a non-opioid pain medication. Nektar is listed on the NASDAQ exchange under the ticker symbol NKTR.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Nektar Therapeutics | -1.229% | -1.229% | 139.636% | -89.171% |
| iShares Core DAX® | 0.051% | 5.593% | 14.403% | 19.767% |
| iShares Nasdaq 100 | 1.808% | 7.445% | 34.917% | 57.237% |
| iShares Nikkei 225® | 2.181% | 2.815% | 11.116% | 8.873% |
| iShares S&P 500 | 1.040% | 4.975% | 27.631% | 48.786% |
Comments by kyron7htx for this prediction
In the thread Nektar Therapeutics diskutieren
US6402681083
Wie sooft bei den Amis könnte der Abverkauf etwas übertrieben sein.
Stopped prediction by kyron7htx for Nektar Therapeutics
Nektar Therapeutics
Start price
Target price
Perf. (%)
€30.16
12.06.19
12.06.19
€54.12
04.11.21
04.11.21
-55.19%
17.07.21
17.07.21
Nektar Therapeutics
Start price
Target price
Perf. (%)
€36.60
22.02.19
22.02.19
€67.65
12.06.19
12.06.19
-17.59%
12.06.19
12.06.19